System Reduces Hyperglycemia, Readmissions and Length of Stay
Sentara Healthcare, a 12-hospital, not-for-profit health system serving Virginia and northeastern North Carolina, has achieved significant improvements in inpatient glycemic management through the use of an eGlycemic Management System.
Sentara Healthcare, a 12-hospital, not-for-profit health system serving Virginia and northeastern North Carolina, has achieved significant improvements in inpatient glycemic management through the use of an eGlycemic Management System.
Developed by Greenville, S.C.-based Glytec, the cloud-based system integrates with electronic health records, improving workflow and nursing efficiency. In addition, eGMS includes advanced clinical and business intelligence analytics and real-time surveillance capabilities.
The health system was able to realize a 79 percent improvement over the national average for hyperglycemia across eight hospitals. Additionally, these hospitals achieved an overall hypoglycemia rate of 0.83 percent for IV and subcutaneous insulin therapy. Through improved glycemic management initiatives, Sentara was able to dramatically reduce readmissions and length of stay, as well as improve patient safety.
Not only has the system resulted in excellent and sustainable improvements in patient quality and safety for Sentara, but at this stage we have data indicating it has also successfully reduced avoidable readmissions and shortened length of stay by, on average, an entire day. We will be publishing a large outcomes study looking at the impact of Glytecs system on these metrics, said Paul Chidester, M.D., vice president of medical affairs at Sentara Norfolk General Hospital.
Almost 40 percent of all patients admitted to acute care hospitals in the U.S. experience dysglycemia (abnormal blood glucose levels) during their stay, which can result in increased rates of infection and mortality, longer lengths of stay and a higher probability of readmission.
Developed by Greenville, S.C.-based Glytec, the cloud-based system integrates with electronic health records, improving workflow and nursing efficiency. In addition, eGMS includes advanced clinical and business intelligence analytics and real-time surveillance capabilities.
The health system was able to realize a 79 percent improvement over the national average for hyperglycemia across eight hospitals. Additionally, these hospitals achieved an overall hypoglycemia rate of 0.83 percent for IV and subcutaneous insulin therapy. Through improved glycemic management initiatives, Sentara was able to dramatically reduce readmissions and length of stay, as well as improve patient safety.
Not only has the system resulted in excellent and sustainable improvements in patient quality and safety for Sentara, but at this stage we have data indicating it has also successfully reduced avoidable readmissions and shortened length of stay by, on average, an entire day. We will be publishing a large outcomes study looking at the impact of Glytecs system on these metrics, said Paul Chidester, M.D., vice president of medical affairs at Sentara Norfolk General Hospital.
Almost 40 percent of all patients admitted to acute care hospitals in the U.S. experience dysglycemia (abnormal blood glucose levels) during their stay, which can result in increased rates of infection and mortality, longer lengths of stay and a higher probability of readmission.
More for you
Loading data for hdm_tax_topic #better-outcomes...